Production (Stage)
BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 3.30K | 12.50K | 900.00 | 3.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 3.30K | 12.50K | 900.00 | 3.10K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 3.30K | 12.50K | 900.00 | 3.10K |
| SG&A Expenses | 1.17M | 589.30K | 612.70K | 307.50K | 650.10K |
| Depreciation & Amortization | -4.10K | 16.30K | 16.90K | 16.70K | 17.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28M | 769.70K | 979.90K | 526.00K | 998.80K |
| Operating Income | -1.28M | -766.40K | -967.40K | -525.20K | -995.70K |
| Income Before Tax | -1.38M | -991.00K | -1.07M | -712.10K | -1.17M |
| Income Tax Expenses | -- | -64.10K | -- | -- | -- |
| Earnings from Continuing Operations | -1.38M | -926.80K | -1.07M | -712.10K | -1.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.38M | -926.80K | -1.07M | -712.10K | -1.17M |
| EBIT | -1.28M | -766.40K | -967.40K | -525.20K | -995.70K |
| EBITDA | -1.26M | -750.10K | -950.50K | -508.50K | -978.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 115.37M | 113.38M | 113.02M | 109.74M | 108.99M |
| Average Diluted Shares Outstanding | 115.37M | 113.38M | 113.02M | 109.74M | 108.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |